vimarsana.com

Page 5 - புதியது மருந்து சமர்ப்பிப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NA Proactive news snapshot: Cloud DX Inc, Golden Tag Resources Ltd, TechX Technologies Inc, Viscount Mining Corp, LexaGene Holdings Inc UPDATE …

NA Proactive news snapshot: Cloud DX Inc, Golden Tag Resources Ltd, TechX Technologies Inc, Viscount Mining Corp, LexaGene Holdings Inc UPDATE …
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Tetra Bio-Pharma Provides Update on Its New Drug Submission Application in Canada

Tetra Bio-Pharma Provides Update on Its New Drug Submission Application in Canada The addressable market is estimated to be $80M CDN by 2022 OTTAWA, ON / ACCESSWIRE / April 14, 2021 / Tetra Bio-Pharma Inc. ( Tetra or the Company ) (TSX:TBP)(OTCQB:TBPMF)(FRA:JAM1), a biopharmaceutical pioneer in immunomodulator drug discovery and development announce they have advanced the REDUVO soft gel capsules New Drug Submission (NDS) file by responding to a request for more information from Health Canada, as previously announced on March 15, 2021. This review is part of the overall requirement for Tetra to be able to sell and distribute REDUVO soft gel capsules in Canada.

NA Proactive news snapshot: Golden Tag Resources Ltd, TechX Technologies Inc, Viscount Mining Corp, LexaGene Holdings Inc UPDATE …

NA Proactive news snapshot: Golden Tag Resources Ltd, TechX Technologies Inc, Viscount Mining Corp, LexaGene Holdings Inc UPDATE …
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Tetra Bio-Pharma Receives Second Compliant Rating on Inspection from Health Canada

Tetra Bio-Pharma Receives Second Compliant Rating on Inspection from Health Canada Key milestone in the development path to commercialization of Reduvo OTTAWA, ON / ACCESSWIRE / April 1, 2021 / Tetra Bio-Pharma Inc. ( Tetra or the Company ) (TSX:TBP)(OTCQB:TBPMF)(FRA:JAM1), a biopharmaceutical pioneer in immunomodulator drug discovery and development announce they have received a notice of compliance for its Drug Establishment License (DEL) following an audit by the Drug GMP Inspection Program of Health Canada. Guy Chamberland, CEO and CRO of Tetra Bio-Pharma stated, This is a critical step in the regulatory process for drug approval. Tetra s robust GMP quality management system is in place to ensure product quality and consumer safety. This Compliance rating signifies that we are one step closer to our goal of bringing Reduvo soft gel capsules to market in 2021.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.